Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Learn how to unlock additional credit card perks. Enhance your benefits and enjoy more rewards!
15,641 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Urban Outfitters posted a strong Q4 2026 with record revenue, led by a rebound in its flagship Urban Outfitters brand...
BigBear.ai has emerged as a key name in enterprise AI and decision intelligence. This guide breaks down bigbear.ai (b...
As Omada Health eyes the 2025 earnings journey, investors want a clear read on growth, margins, and risks. This guide...
Berkshire Hathaway just repurchased stock, signaling a shift in how the company’s massive cash pile may be deployed. ...
Nvidia has dazzled investors with AI-driven growth, but a hidden threat could derail the rally. This article identifi...
A five-year AI infrastructure deal worth up to $27 billion between Nebius and Meta sparked a broad rally in lumentum,...
As Enhabit prepares to report its first-quarter results, investors need a clear playbook. This guide breaks down what...
Lululemon faces renewed headwinds as leadership shifts and governance questions surface. This comprehensive look brea...
Pitney Bowes is navigating a pivot from legacy mailing services to software, data, and commerce solutions. This break...
Curious about a nuclear-tech stock with big growth potential? This guide breaks down the case for buying oklo stock t...
CoreWeave's stock has fallen sharply in May as costs rise and guidance disappoints. This guide breaks down the reason...